BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,943,000 | -33.9% | 349,500 | -0.1% | 0.03% | -33.3% |
Q1 2017 | $2,940,000 | +15.3% | 350,000 | -13.1% | 0.04% | +21.9% |
Q4 2016 | $2,549,000 | +59.2% | 402,600 | +10.9% | 0.03% | +88.2% |
Q3 2016 | $1,601,000 | +114.3% | 363,100 | +38.0% | 0.02% | +112.5% |
Q2 2016 | $747,000 | +0.3% | 263,100 | 0.0% | 0.01% | +33.3% |
Q1 2016 | $745,000 | – | 263,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,076,924 | 27.82% |
Prosight Management, LP | 5,000,000 | $35,200,000 | 5.27% |
Saturn V Capital Management LP | 954,856 | $6,722,186 | 3.73% |
ORACLE INVESTMENT MANAGEMENT INC | 555,522 | $3,910,875 | 2.88% |
Kynam Capital Management, LP | 2,848,197 | $20,051,307 | 2.76% |
TANG CAPITAL MANAGEMENT LLC | 2,450,000 | $17,248,000 | 2.54% |
AlphaCentric Advisors LLC | 570,000 | $4,012,800 | 2.23% |
SILVERARC CAPITAL MANAGEMENT, LLC | 760,904 | $5,356,764 | 1.66% |
Eversept Partners, LP | 2,372,113 | $16,699,676 | 1.40% |
Avoro Capital Advisors LLC | 12,055,000 | $84,867,200 | 1.15% |